VC Stock Analysis: Visteon | NASDAQ
Auto Parts | NASDAQ, USA | Market Cap: 2.879m USD | 12M Return: -0.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 74.1M
EPS Trend: 8.3%
Qual. Beats: 0
Rev. Trend: -96.5%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Visteon Corporation is a U.S.-based automotive technology company that designs, manufactures, and sells automotive electronics and connected car solutions primarily to vehicle manufacturers (OEMs). Its product portfolio spans instrument clusters, information displays, infotainment and connected car systems (including Android-based platforms and AI voice assistants), battery management systems, power electronics units, and its SmartCore integrated domain controller family, along with an in-house AI software platform called CognitoAI. The company also provides engineering and software development services. Visteon operates globally, with facilities in North America, Europe, Asia (including China, India, and Japan), and South America, and is headquartered in Van Buren, Michigan, having been incorporated in 2000.
As a Tier 1 supplier in the automotive value chain, Visteon sells directly to vehicle manufacturers rather than to end consumers, which ties its revenue cycle to global vehicle production trends. Within the GICS classification, it falls under Consumer Discretionary in the Automotive Parts & Equipment sub-industry, reflecting its position as a components and systems supplier rather than a finished-vehicle producer.
- Electric vehicle adoption boosts battery management system orders
- China auto demand weakness pressures cockpit electronics revenue
- SmartCore domain controller wins accelerate digital cockpit revenue mix
| Net Income: 167.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.58 > 1.0 |
| NWC/Revenue: 20.27% < 20% (prev 19.91%; Δ 0.36% < -1%) |
| CFO/TA 0.10 > 3% & CFO 346.0m > Net Income 167.0m |
| Net Debt (-105.0m) to EBITDA (412.0m): -0.25 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.7m) vs 12m ago 0.73% < -2% |
| Gross Margin: 13.38% > 18% (prev 14.22%; Δ -0.84% > 0.5%) |
| Asset Turnover: 118.0% > 50% (prev 129.0%; Δ -11.02% > 0%) |
| Interest Coverage Ratio: 42.71 > 6 (EBIT TTM 299.0m / Interest Expense TTM 7.00m) |
| A: 0.22 (Total Current Assets 1.82b - Total Current Liabilities 1.05b) / Total Assets 3.42b |
| B: 0.84 (Retained Earnings 2.86b / Total Assets 3.42b) |
| C: 0.09 (EBIT TTM 299.0m / Avg Total Assets 3.21b) |
| D: 0.87 (Book Value of Equity 1.56b / Total Liabilities 1.78b) |
| Altman-Z'' = 5.74 = AAA |
| DSRI: 1.14 (Receivables 757.0m/675.0m, Revenue 3.79b/3.87b) |
| GMI: 1.06 (GM 14.22% / 13.38%) |
| AQI: 1.17 (AQ_t 0.28 / AQ_t-1 0.24) |
| SGI: 0.98 (Revenue 3.79b / 3.87b) |
| TATA: -0.05 (NI 167.0m - CFO 346.0m) / TA 3.42b) |
| Beneish M = -2.77 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 106.58 with a total of 452,087 shares traded. Over the past week, the price has changed by +4.03%, over one month by -9.45%, over three months by +13.74% and over the past year by -0.38%.
Current recommended Stop Loss: 99.40 (which is 6.7% or 1.3 ATR below the current price).
Visteon has received a consensus analysts rating of 3.73. Therefore, it is recommended to hold VC.
- StrongBuy: 5
- Buy: 1
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 133.8 | 25.5% |
P/E Trailing = 18.0351
P/E Forward = 11.7371
P/S = 0.722
P/B = 1.7576
P/EG = 1.0072
Revenue TTM = 3.79b USD
EBIT TTM = 299.0m USD
EBITDA TTM = 412.0m USD
Long Term Debt = 279.0m USD (from longTermDebt, last quarter)
Short Term Debt = 42.0m USD (from shortTermDebt, last quarter)
Debt = 575.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 139.0m
Net Debt = -105.0m USD (calculated: Debt 575.0m - CCE 680.0m)
Enterprise Value = 2.77b USD (2.88b + Debt 575.0m - CCE 680.0m)
Interest Coverage Ratio = 42.71 (Ebit TTM 299.0m / Interest Expense TTM 7.00m)
EV/FCF = 13.08x (Enterprise Value 2.77b / FCF TTM 212.0m)
FCF Yield = 7.64% (FCF TTM 212.0m / Enterprise Value 2.77b)
FCF Margin = 5.60% (FCF TTM 212.0m / Revenue TTM 3.79b)
Net Margin = 4.41% (Net Income TTM 167.0m / Revenue TTM 3.79b)
Gross Margin = 13.38% ((Revenue TTM 3.79b - Cost of Revenue TTM 3.28b) / Revenue TTM)
Gross Margin QoQ = 11.84% (prev 12.87%)
Tobins Q-Ratio = 0.81 (Enterprise Value 2.77b / Total Assets 3.42b)
Interest Expense / Debt = 1.22% (Interest Expense 7.00m / Debt 575.0m)
Taxrate = 38.70% (113.0m / 292.0m)
NOPAT = 183.3m (EBIT 299.0m * (1 - 38.70%))
Current Ratio = 1.73 (Total Current Assets 1.82b / Total Current Liabilities 1.05b)
Debt / Equity = 0.37 (Debt 575.0m / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = -0.25 (Net Debt -105.0m / EBITDA 412.0m)
Debt / FCF = -0.50 (Net Debt -105.0m / FCF TTM 212.0m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 167.0m / Total Assets 3.42b)
RoE = 11.08% (Net Income TTM 167.0m / Total Stockholder Equity 1.51b)
RoCE = 16.74% (EBIT 299.0m / Capital Employed (Equity 1.51b + L.T.Debt 279.0m))
RoIC = 8.25% (NOPAT 183.3m / Invested Capital 2.22b)
WACC = 8.23% (E(2.88b)/V(3.45b) * Re(9.72%) + D(575.0m)/V(3.45b) * Rd(1.22%) * (1-Tc(0.39)))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -58.04 | Cagr: -0.79%
[DCF] Terminal Value 73.10% ; FCFF base≈244.4m ; Y1≈214.3m ; Y5≈173.2m
[DCF] Fair Price = 108.1 (EV 2.78b - Net Debt -105.0m = Equity 2.88b / Shares 26.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 8.33 | EPS CAGR: 4.05% | SUE: -0.24 | # QB: 0
Revenue Correlation: -96.53 | Revenue CAGR: -2.58% | SUE: 2.05 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.19 | Chg30d=+1.64% | Revisions=+55% | Analysts=11
EPS next Quarter (2026-09-30): EPS=2.36 | Chg30d=+3.19% | Revisions=+58% | Analysts=11
EPS current Year (2026-12-31): EPS=8.58 | Chg30d=+1.03% | Revisions=+58% | GrowthEPS=+10.7% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=10.14 | Chg30d=+4.00% | Revisions=+75% | GrowthEPS=+18.2% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: +76% (up=32, down=3)